E-cigarette advocates like to point out that because there is no combustion, e-cigarettes expose users to lower levels of many carcinogens (cancer-causing chemicals). Even so, there are still some carcinogens in e-cigarette aerosol exposure to e-cigarette aerosol damages DNA and reduces repair in animal and human cells and causes cancer in animals. Now there isContinue reading “First epidemiological evidence linking e-cigs to cancer in people”
Author Archives: Stanton Glantz
Here’s an approachable introduction to the growing collection of industry insider documents on opioids, free to all
Caleb Alexander, together with colleagues at Johns Hopkins, UCSF and I just published “The Opioid Industry Documents Archive: A Living Digital Repository” in American Journal of Public Health. This paper describes the growing Opioid Industry Documents Archive that is part of the UCSF Industry Documents Library and outlines opportunities for research and public education withContinue reading “Here’s an approachable introduction to the growing collection of industry insider documents on opioids, free to all”
Outside review of FDA CTP operations brings opportunities and risks
FDA Commissioner Rob Califf announced (Politico, Associated Press, New York Times) that he was asking the Regan-Udall Foundation to conduct a process review of the FDA’s tobacco and food centers. As someone who has been critical of the poor and incomplete scientific assessments FDA has completed of so-called “harm reduction” products — particularly e-cigarettes andContinue reading “Outside review of FDA CTP operations brings opportunities and risks”
Since FDA has made a mess of Juul, the health community & Congress should force FDA to ban menthol e-cigs now
The day after FDA denied Juul’s application to continue selling its e-cigarettes on June 23, 2022, Juul sued and obtained an emergency Stay from the US Court of Appeals. On July 5, the FDA announced that it was issuing its own Administrative Stay and allowed Juul to remain on the market while the FDA considersContinue reading “Since FDA has made a mess of Juul, the health community & Congress should force FDA to ban menthol e-cigs now”
As a matter of health equity and social justice, FDA should immediately finalize and implement the proposed standard for menthol in cigarettes to reduce smoking-attributable deaths and health disparities among African Americans
Several colleagues at UCSF and elsewhere and I submitted this comment to the FDA on its proposed rule to end menthol in cigarettes. A PDF is here; the regulations.gov tracking number is l4s-xj6c-9kba. As a matter of health equity and social justice, FDA should immediately finalize and implement the proposed standard for menthol in cigarettesContinue reading “As a matter of health equity and social justice, FDA should immediately finalize and implement the proposed standard for menthol in cigarettes to reduce smoking-attributable deaths and health disparities among African Americans”
White House OKs FDA moving forward on reducing nicotine in cigs; FDA can and should ban menthol ecigs now
On June 21, 2022, the Biden Administration announced that FDA would be moving forward to develop a product standard limiting nicotine in cigarettes and other combusted tobacco products to nonaddictive levels. FDA has been formally considering such a rule for a long time. In 2018, FDA solicited public comment on such a rule. At thatContinue reading “White House OKs FDA moving forward on reducing nicotine in cigs; FDA can and should ban menthol ecigs now”
FDA should finalize the proposed rule prohibiting characterizing flavors in cigars and make it effective 90 days after publication of the final rule
My colleagues and I submitted this public comment to FDA urging them not to extend the comment period for the rule ending flavored cigars, as the tobacco companies have requested. Using the FDA’s own analysis cutting the shortening the effective date by nine months (from one-year to 90-days) would prevent an additional 396,000 people fromContinue reading “FDA should finalize the proposed rule prohibiting characterizing flavors in cigars and make it effective 90 days after publication of the final rule”
FDA should not give the tobacco companies more time to submit public comments about the proposed rule ending characterizing flavors in cigars
My colleagues and I submitted this public comment to FDA urging them not to extend the comment period for the rule ending flavored cigars, as the tobacco companies have requested. According to the FDA’s own analysis granting the 3 month delay would cost 60 lives and an additional $1.17-$1.43 billion in costs. The industry hasContinue reading “FDA should not give the tobacco companies more time to submit public comments about the proposed rule ending characterizing flavors in cigars”
Health groups call on Netflix to honor its promise to get smoking out of its kid programming
Sixteen health organizations and four individuals wrote Netflix on June 6, reminding them that last year Netflix pledged to get rid of smoking in their programming that appeals to youth. Netflix never published a formal policy and, judging from the smoke-filled new season on Stranger Things, doesn’t care how many kids it delivers to BigContinue reading “Health groups call on Netflix to honor its promise to get smoking out of its kid programming”
Support for cigarette menthol ban and cigar flavor ban; need to ban menthol as an ingredient not just as a characterizing flavor and to eliminate exceptions for some tobacco products (Statement at June 13, 2022 FDA Listening Session)
My name is Stanton Glantz. I am a retired Professor of Medicine at the University of California San Francisco and was the principal investigator of the UCSF Tobacco Center of Regulatory Science. The FDA did an excellent job of summarizing the science on the effects of menthol to build a justification for ending the useContinue reading “Support for cigarette menthol ban and cigar flavor ban; need to ban menthol as an ingredient not just as a characterizing flavor and to eliminate exceptions for some tobacco products (Statement at June 13, 2022 FDA Listening Session)”
Stanton Glantz blog 